Abeona Therapeutics Inc Sustainability Reports

Abeona Therapeutics Inc. is a commercial-stage biopharmaceutical company focused on developing and manufacturing innovative cell and gene therapies for life-threatening rare genetic diseases.

Sector: Manufacturing

Country: United States

Exchange: Nasdaq

LEI: 54930002Z8PIJRCB4576

FIGI: BBG001S8T7K0

4 reports from 2016 to 2025

• Abeona Therapeutics Inc 2025 Annual Report on Form 10-K
• Abeona Therapeutics Inc 2023 Annual Report on Form 10-K
• Abeona Therapeutics Inc 2022 Annual Report on Form 10-K
• Abeona Therapeutics Inc 2016 Annual Report